Profile data is unavailable for this security.
About the company
DENTSPLY SIRONA Inc. is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies. The dental industry encompasses the diagnosis, treatment and prevention of disease and ailments of the teeth, gums and supporting bone. Its principal dental product categories are dental consumable products, dental laboratory products, dental specialty products and dental equipment. Additionally, its consumable medical device products are used for urological and surgical applications. These products are produced by the Company in the United States and internationally and are distributed throughout the world under various brand names, including ANKYLOS, AQUASIL ULTRA, ARTICADENT, ATLANTIS, CALIBRA, CAULK, CAVITRON, CELTRA, DELTON, DENTSPLY, DETREY and DYRACT.
- Revenue in USD (TTM)3.37bn
- Net income in USD-79.20m
- Incorporated1983
- Employees15.20k
- LocationDENTSPLY SIRONA Inc13320 Ballantyne Corporate PlCHARLOTTE 28277-3607United StatesUSA
- Phone+1 (717) 845-7511
- Fax+1 (302) 636-5454
- Websitehttps://www.dentsplysirona.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MSA Safety Inc | 1.34bn | 138.78m | 5.42bn | 4.80k | 39.40 | 7.05 | 30.33 | 4.06 | 3.53 | 3.53 | 33.97 | 19.83 | 0.7648 | 3.31 | 5.59 | 278,172.90 | 8.02 | 6.18 | 9.55 | 7.49 | 44.79 | 45.06 | 10.48 | 7.51 | 1.73 | 13.26 | 0.3046 | 57.95 | 3.23 | 4.34 | 11.66 | 9.60 | 1.74 | 5.92 |
| Globus Medical Inc | 767.26m | 94.86m | 5.67bn | 2.00k | 62.33 | 4.00 | 36.64 | 7.40 | 0.9227 | 0.9227 | 7.61 | 14.36 | 0.5126 | 0.9805 | 5.39 | 383,632.00 | 6.34 | 12.31 | 6.78 | 13.46 | 73.23 | 76.66 | 12.36 | 19.96 | 5.80 | -- | 0.00 | 0.00 | 10.15 | 10.61 | -0.8078 | 10.91 | 23.37 | -- |
| Haemonetics Corporation | 902.53m | 106.15m | 5.72bn | 3.00k | 54.42 | 8.55 | 28.09 | 6.34 | 2.07 | 2.07 | 17.59 | 13.17 | 0.6919 | 1.69 | 5.68 | 300,441.10 | 8.14 | 1.91 | 10.46 | 2.37 | 48.49 | 45.60 | 11.76 | 2.64 | 1.34 | 8.81 | 0.4099 | 0.00 | 2.16 | 1.66 | 39.09 | 35.27 | -16.79 | -- |
| Tandem Diabetes Care Inc | 439.16m | -48.73m | 5.83bn | 1.04k | -- | 17.84 | -- | 13.28 | -0.8056 | -0.8056 | 7.29 | 5.26 | 0.9096 | 3.75 | 9.02 | 421,057.50 | -10.09 | -56.67 | -12.83 | -79.84 | 52.43 | 46.65 | -11.10 | -52.77 | 4.94 | -0.9372 | 0.3788 | -- | 97.05 | 48.77 | 79.81 | -- | 34.70 | -- |
| Nevro Corp | 366.69m | -89.68m | 5.94bn | 853.00 | -- | 15.64 | -- | 16.20 | -2.72 | -2.72 | 11.16 | 11.03 | 0.5981 | 1.28 | 4.90 | 429,883.90 | -14.63 | -14.62 | -19.53 | -16.64 | 69.47 | 68.74 | -24.46 | -20.59 | 2.75 | -4.76 | 0.4463 | -- | 0.7658 | 64.32 | -110.72 | -- | 40.91 | -- |
| Henry Schein, Inc. | 9.62bn | 591.50m | 9.07bn | 19.00k | 15.61 | 2.87 | 15.09 | 0.9422 | 4.07 | 4.06 | 66.84 | 22.15 | 1.29 | 4.86 | 7.16 | 506,439.80 | 5.52 | 6.75 | 9.62 | 12.07 | 28.74 | 29.67 | 4.27 | 4.85 | 0.924 | 20.71 | 0.217 | 0.00 | 6.03 | -0.7549 | 67.21 | 8.50 | -1.48 | -- |
| Penumbra Inc | 538.78m | -25.28m | 9.28bn | 2.70k | -- | 14.91 | -- | 17.22 | -0.7092 | -0.2755 | 14.93 | 17.15 | 0.7565 | 1.19 | 5.02 | 199,547.00 | -3.96 | 4.81 | -4.57 | 5.47 | 63.48 | 66.26 | -5.24 | 5.30 | 3.69 | -- | 0.0443 | 0.00 | 23.03 | 34.25 | 625.85 | -- | 41.57 | -- |
| DENTSPLY SIRONA Inc | 3.37bn | -79.20m | 10.68bn | 15.20k | -- | 2.24 | 43.49 | 3.17 | -0.3633 | -0.3633 | 15.31 | 21.79 | 0.3906 | 3.06 | 5.08 | 221,789.50 | -0.9164 | -3.84 | -1.04 | -4.25 | 50.33 | 53.94 | -2.35 | -8.67 | 1.77 | -- | 0.3185 | -- | 1.08 | 6.63 | 125.90 | -4.03 | 3.05 | 7.50 |
| ABIOMED, Inc. | 802.86m | 207.82m | 12.23bn | 1.54k | 59.40 | 10.34 | 53.09 | 15.23 | 4.56 | 4.56 | 17.61 | 26.17 | 0.6548 | 1.78 | 9.16 | 522,692.70 | 16.95 | 19.09 | 18.60 | 21.43 | 80.81 | 83.20 | 25.88 | 23.02 | 6.02 | -- | 0.00 | 0.00 | 9.29 | 29.56 | -21.62 | 12.29 | 53.36 | -- |
| Masimo Corporation | 1.10bn | 222.55m | 13.57bn | 1.60k | 64.02 | 9.59 | 54.35 | 12.38 | 3.85 | 3.85 | 18.96 | 25.70 | 0.7242 | 2.37 | 7.86 | 685,125.00 | 14.70 | 22.09 | 16.83 | 26.76 | 65.96 | 66.54 | 20.30 | 25.09 | 4.10 | -- | 0.00 | 0.00 | 9.27 | 9.84 | 0.9118 | 22.03 | -1.70 | -- |
| Varian Medical Systems, Inc. | 3.17bn | 273.00m | 15.83bn | 10.06k | 58.27 | 7.63 | 59.41 | 5.00 | 2.98 | 2.94 | 34.61 | 22.77 | 0.7395 | 3.35 | 2.91 | -- | 6.38 | 7.99 | 11.38 | 14.28 | 43.47 | 42.96 | 8.62 | 10.16 | 1.12 | -- | 0.1455 | -- | -1.76 | 4.93 | -8.96 | -2.68 | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 30 Sep 2020 | 23.04m | 10.55% |
| Generation Investment Management LLPas of 30 Sep 2020 | 19.34m | 8.85% |
| Artisan Partners LPas of 30 Sep 2020 | 15.49m | 7.09% |
| BlackRock Fund Advisorsas of 30 Sep 2020 | 10.79m | 4.94% |
| SSgA Funds Management, Inc.as of 30 Sep 2020 | 10.01m | 4.58% |
| T. Rowe Price Associates, Inc. (Investment Management)as of 30 Sep 2020 | 9.58m | 4.38% |
| Atlanta Capital Management Co. LLCas of 30 Sep 2020 | 8.45m | 3.87% |
| Janus Capital Management LLCas of 30 Sep 2020 | 8.25m | 3.78% |
| Nuance Investments LLCas of 30 Sep 2020 | 7.32m | 3.35% |
| First Eagle Investment Management LLCas of 30 Sep 2020 | 7.28m | 3.33% |
